Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR2C3 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | SH3BGRL3 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | U2SURP | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | GNPAT | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | NR1D1 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | MRGPRF | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | NUFIP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | FAM98B | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | CHD1L | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | EPS8 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |